Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial.

ABSTRACT:

SUBMITTER: Feigl B 

PROVIDER: S-EPMC10867415 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature